Atlas Trials

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Clinical trial NCT06100289 · RECRUITING

Trial details

NCT number
NCT06100289
Sponsor
Takeda
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Ulcerative ColitisCrohn's Disease
Start date
2025-01-22
Primary completion
2028-05-16
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.